| Predicate |
Object |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 |
| filingDate |
2003-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba43af93a289e73ec7f2584b642f6ffa |
| publicationDate |
2003-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2003207819-A1 |
| titleOfInvention |
Compositions and methods for treating inflammatory connective tissue diseases |
| abstract |
The invention provides compositions and methods utilizing 14- and 15-member macrolide antibiotics for the treatment of patients with connective tissue diseases. The methods of the invention provide for the administration to a patient of a therapeutically effective amount of a 14-member macrolide antibiotic, a 15-member macrolide antibiotic, pharmaceutically acceptable derivatives thereof, and combinations thereof for a period of time sufficient to obtain a desired alleviation of one or more symptoms of the connective tissue disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2688481-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11000533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2688481-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7468428-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016025533-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007135504-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8865749-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007149452-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802707-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2011363947-B2 |
| priorityDate |
2002-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |